# A Phase IV Study of Huazhi Rougan Granule

> **NCT06188611** · PHASE4 · COMPLETED · sponsor: **Shandong New Time Pharmaceutical Co., LTD** · enrollment: 282 (actual)

## Conditions studied

- A Phase IV Trial to Investigate the Efficacy and Safety of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver

## Interventions

- **DRUG:** Huazhi Rougan Granule Placebo granule

## Key facts

- **NCT ID:** NCT06188611
- **Lead sponsor:** Shandong New Time Pharmaceutical Co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-18
- **Primary completion:** 2018-11-08
- **Final completion:** 2018-11-08
- **Target enrollment:** 282 (ACTUAL)
- **Last updated:** 2024-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06188611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06188611, "A Phase IV Study of Huazhi Rougan Granule". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06188611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*